For: | Grassi A, Ballardini G. Hepatitis C in injection drug users: It is time to treat. World J Gastroenterol 2017; 23(20): 3569-3571 [PMID: 28611509 DOI: 10.3748/wjg.v23.i20.3569] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i20/3569.htm |
Number | Citing Articles |
1 |
Abdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis. Harm Reduction Journal 2021; 18(1) doi: 10.1186/s12954-020-00441-9
|
2 |
Erin Kelty, Agata Chrzanowska, David B. Preen. Handbook of Substance Misuse and Addictions. 2022; : 1851 doi: 10.1007/978-3-030-92392-1_96
|
3 |
Javier Crespo, Pablo Lázaro, Antonio Javier Blasco, Antonio Aguilera, Javier García-Samaniego, José María Eiros, José Luis Calleja, Federico García. Diagnóstico en un solo paso de la hepatitis C en 2019: una realidad en España. Enfermedades Infecciosas y Microbiología Clínica 2021; 39(3): 119 doi: 10.1016/j.eimc.2020.03.004
|
4 |
C. Corey Hardin, Katherine M. Rich, Daniel A. Solomon. Medical Complications of Injection Drug Use — Part II. NEJM Evidence 2023; 2(3) doi: 10.1056/EVIDra2300019
|
5 |
Erin Kelty, Agata Chrzanowska, David B. Preen. Handbook of Substance Misuse and Addictions. 2022; : 1 doi: 10.1007/978-3-030-67928-6_96-1
|
6 |
Michal Ordak, Tadeusz Nasierowski, Karolina Pawlik, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010–19. International Journal of Psychiatry in Clinical Practice 2020; 24(3): 322 doi: 10.1080/13651501.2020.1771375
|
7 |
Anissa Chouikha, Amine Ghrabi, Amira Ghodbane, Walid Hammemi, Marwa Khedhiri, Amel Sadraoui, Henda Touzi, Hichem Ben Hassine, Sonia Maatoug, Chaima Bensaoud, Sonia Abdelhak, Samir Bouarrouj, Mariem Gdoura, Hedia Chaouachi, Henda Triki. Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.697859
|
8 |
Allison E. Wang, Eric Hsieh, Barbara J. Turner, Norah Terrault. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts. Journal of General Internal Medicine 2022; 37(13): 3435 doi: 10.1007/s11606-022-07628-9
|
9 |
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. Clinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
|
10 |
Kimberly Dion, Lisa Chiodo, Liz Whynott, Brita Loftus, Pedro Alvarez, Jillian Shanahan, Gabriel Quaglia, Antonio Roman, Elizabeth Sorbi, Donna Wilkins-Carmody. Exploration of the unmet health care needs of people who inject drugs. Journal of the American Association of Nurse Practitioners 2020; 32(1): 60 doi: 10.1097/JXX.0000000000000201
|
11 |
Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, Jesús Troya, Guillermo Cuevas, Jorge Gutiérrez, Santiago Moreno, Jason Blackard. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination. PLOS ONE 2018; 13(10): e0204795 doi: 10.1371/journal.pone.0204795
|
12 |
Mohan B. Sannathimmappa, Latifa Zehri, Ayat A. M. Al Zadjali, Halima M. A. Albalushi, Buthaina A. A. H. Al Saadi, Rajeev Aravindakshan, Elham S. Al-Risi, Saleema Al-Maqbali, Vinod Nambiar. Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study. Journal of Education and Health Promotion 2024; 13(1) doi: 10.4103/jehp.jehp_1326_23
|
13 |
Javier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, Antonio Aguilera Guirao, Javier García-Samaniego Rey, José María Eiros Bouza, José Luis Calleja Panero, Federico García. El diagnóstico de la infección por el virus de la hepatitis C en España: una oportunidad para mejorar. Enfermedades Infecciosas y Microbiología Clínica 2019; 37(4): 231 doi: 10.1016/j.eimc.2018.05.016
|
14 |
Javier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, Antonio Aguilera Guirao, Javier García-Samaniego Rey, José María Eiros Bouza, José Luis Calleja Panero, Federico García. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve. Enfermedades infecciosas y microbiologia clinica (English ed.) 2019; 37(4): 231 doi: 10.1016/j.eimce.2019.02.006
|
15 |
Masoud Behzadifar, Meysam Behzadifar, Nicola Luigi Bragazzi. A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran. BMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-8175-1
|
16 |
Sulochan GC, Ashok Khanal, Vijay S. GC, Suman Bhattarai, Suresh Panthee, Aashis Khanal, Amrit Gaire, Sagar Poudel, Rakesh Ghimire, Sharada P. Wasti, Huachun Zou. Burden of tuberculosis and hepatitis co-infection among people living with HIV in Nepal: a systematic review and meta-analysis. Sexual Health 2022; 19(5): 406 doi: 10.1071/SH21216
|
17 |
Branka Petković, Srđan Kesić, Slavica Ristić, Željko Pavković, Jelena Podgorac, Gordana Stojadinović, Vesna Pešić. A New Look at an Old Drug: Cumulative Effects of Low Ribavirin Doses in Amphetamine-Sensitized Rats. Current Pharmaceutical Design 2020; 26(31): 3884 doi: 10.2174/1381612826666200326125821
|
18 |
Shoshana H Bardach, Amanda N Perry, Elizabeth Eccles, Elizabeth A Carpenter-Song, Ryan Fowler, Erin M Miers, Anais Ovalle, David de Gijsel. Coproduction of Low-Barrier Hepatitis C Virus and HIV Care for People Who Use Drugs in a Rural Community: Brief Qualitative Report. Journal of Participatory Medicine 2023; 15: e47395 doi: 10.2196/47395
|
19 |
Nativa Helena Alves Del‐Rios, Lyriane Apolinário de Araujo, Regina Maria Bringel Martins, Rafael Alves Guimarães, Márcia Alves Dias de Matos, Karlla Antonieta Amorim Caetano, Raquel Silva Pinheiro, Divânia Dias da Silva França, Leandro Nascimento da Silva, Sheila Araújo Teles, Megmar Aparecida dos Santos Carneiro. Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine users. Journal of Medical Virology 2020; 92(8): 1239 doi: 10.1002/jmv.25632
|
20 |
Stephen A. Martin, Jordon Bosse, Amanda Wilson, Phyllis Losikoff, Lisa Chiodo. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care. Addiction Science & Clinical Practice 2018; 13(1) doi: 10.1186/s13722-018-0111-7
|
21 |
Javier Crespo, José María Eiros Bouza, Antonio Javier Blasco Bravo, Pablo Lázaro de Mercado, Antonio Aguilera Guirao, Federico García, Javier García-Samaniego Rey, José Luis Calleja Panero. The efficiency of several one-step testing strategies for the diagnosis of hepatitis C. Revista Española de Enfermedades Digestivas 2018; 111 doi: 10.17235/reed.2018.5810/2018
|
22 |
Harun Mazumder, Md Faruk Hossain, Pratibha Shrestha, Sultan Mahmud, Maidul Husain, Rebeka Ahmed, Yury E. Khudyakov. Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20–59 years: NHANES 2009–2018. PLOS ONE 2024; 19(8): e0309345 doi: 10.1371/journal.pone.0309345
|
23 |
Zunirah Ahmed, Akshay Shetty, David W Victor, Sudha Kodali. Viral hepatitis: A narrative review of hepatitis A–E. World Journal of Meta-Analysis 2022; 10(3): 99-121 doi: 10.13105/wjma.v10.i3.99
Abstract(607) |
Core Tip(621) |
Full Article(HTML)(3154)
|
Full Article (PDF)-1904K(248)
|
Full Article (Word)-898K(61)
|
Audio-44K(1)
|
Peer-Review Report-421K(82)
|
Answering Reviewers-221K(75)
|
Times Cited (0)
|
Total Visits (7756)
|
Open
|
24 |
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV Infection. Journal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
|
25 |
Farzin Khorvash, Behrooz Ataei, Zahra Baghersad, Zahra Boroumandfar. Effectiveness of the Educational-Supportive Program to Improve the Quality of Life Among Patients with Hepatitis C virus (HCV): A Quasi-Experimental Study. Jundishapur Journal of Health Sciences 2022; 14(2) doi: 10.5812/jjhs-121626
|
26 |
Javier Crespo, Pablo Lázaro, Antonio Javier Blasco, Antonio Aguilera, Javier García-Samaniego, José María Eiros, José Luis Calleja, Federico García. Hepatitis C reflex testing in Spain in 2019: A story of success. Enfermedades infecciosas y microbiologia clinica (English ed.) 2021; 39(3): 119 doi: 10.1016/j.eimce.2020.03.005
|
27 |
Miranda S. Moore, Angelica Bocour. Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City. Public Health Reports® 2022; 137(6): 1126 doi: 10.1177/00333549211049263
|